Search research articles
Contact Us
Filters
Showing results (1-10 of 52) with videos related to
Page
of 6
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 5, 2024
To explain the unexplainable in MONARCH 3 overall survival: the restricted mean survival time. Letter to the Editor regarding 'Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2- advanced breast cancer: Final overall survival results of MONARCH 3' by M. P. Goetz et al
A Orlandi, L Mastrantoni, E Bria, et al.
Acta Crystallographica. Section E, Structure Reports Online
|
August 13, 2011
Di-μ-oxido-bis-[(1,4,8,11-tetra-aza-cyclo-tetra-decane-κN,N',N'',N''')dimangan-ese(III,IV)] bis-(tetra-phenyl-borate) chloride acetonitrile disolvate
Marilyn M Olmstead, David W Boyce, Lauren E Bria
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 9, 2008
Progression-free survival as primary end point in advanced non-small-cell lung cancer: does the size matter?
M Di Maio, E Bria, A Rossi, et al.
Anticancer Research
|
June 12, 1999
Antiblastic chemotherapy in the presence of abdominal aorta aneurysm (AAA): guidelines
S Lauro, G Lanzetta, E Bria, et al.
Anticancer Research
|
January 19, 1999
Contralateral solitary testis metastasis antedating renal cell carcinoma: a case-report and review
S Lauro, G Lanzetta, E Bria, et al.
Anticancer Research
|
April 13, 2001
Malignant bronchial Abrikossoff's tumor and small cell lung cancer: a case report and review
S Lauro, L Trasatti, E Bria, et al.
Cancer Biology & Therapy
|
December 3, 2014
2-weekly docetaxel: issues for clinical practice
F Massari, F Maines, E Bria, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
August 23, 2005
Prostate cancer: the role of hormonal therapy
N Salesi, P Carlini, E M Ruggeri, et al.
British Journal of Cancer
|
November 13, 2003
A phase II study of irinotecan plus chronomodulated oxaliplatin, 5-fluorouracil and folinic acid in advanced colorectal cancer patients
C Garufi, E Bria, B Vanni, et al.
Cancer Treatment Reviews
|
August 28, 2017
Tracking MET de-addiction in lung cancer: A road towards the oncogenic target
S Pilotto, L Carbognin, N Karachaliou, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 52) with videos related to
Sort By:
Page
of 6
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 5, 2024
To explain the unexplainable in MONARCH 3 overall survival: the restricted mean survival time. Letter to the Editor regarding 'Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2- advanced breast cancer: Final overall survival results of MONARCH 3' by M. P. Goetz et al
A Orlandi, L Mastrantoni, E Bria, et al.
Acta Crystallographica. Section E, Structure Reports Online
|
August 13, 2011
Di-μ-oxido-bis-[(1,4,8,11-tetra-aza-cyclo-tetra-decane-κN,N',N'',N''')dimangan-ese(III,IV)] bis-(tetra-phenyl-borate) chloride acetonitrile disolvate
Marilyn M Olmstead, David W Boyce, Lauren E Bria
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 9, 2008
Progression-free survival as primary end point in advanced non-small-cell lung cancer: does the size matter?
M Di Maio, E Bria, A Rossi, et al.
Anticancer Research
|
June 12, 1999
Antiblastic chemotherapy in the presence of abdominal aorta aneurysm (AAA): guidelines
S Lauro, G Lanzetta, E Bria, et al.
Anticancer Research
|
January 19, 1999
Contralateral solitary testis metastasis antedating renal cell carcinoma: a case-report and review
S Lauro, G Lanzetta, E Bria, et al.
Anticancer Research
|
April 13, 2001
Malignant bronchial Abrikossoff's tumor and small cell lung cancer: a case report and review
S Lauro, L Trasatti, E Bria, et al.
Cancer Biology & Therapy
|
December 3, 2014
2-weekly docetaxel: issues for clinical practice
F Massari, F Maines, E Bria, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
August 23, 2005
Prostate cancer: the role of hormonal therapy
N Salesi, P Carlini, E M Ruggeri, et al.
British Journal of Cancer
|
November 13, 2003
A phase II study of irinotecan plus chronomodulated oxaliplatin, 5-fluorouracil and folinic acid in advanced colorectal cancer patients
C Garufi, E Bria, B Vanni, et al.
Cancer Treatment Reviews
|
August 28, 2017
Tracking MET de-addiction in lung cancer: A road towards the oncogenic target
S Pilotto, L Carbognin, N Karachaliou, et al.
Page
of 6